MatthewCharlesHiemenzMD

PubMed

• 7 citations
  A multimodal genomics approach to diagnostic evaluation of pediatric hematologic malignancies.
  Matthew C. Hiemenz, Matthew J. Oberley, Andrew Doan, Le Aye, Jianling Ji, Ryan J. Schmidt, Jaclyn A. Biegel, Deepa Bhojwani, Gordana Raca> ;Cancer Genetics. 2021 Jun 1
• 3 citations
  Clinical utility of comprehensive genomic profiling in central nervous system tumors of children and young adults
  Jianling Ji, Kristiyana Kaneva, Matthew C. Hiemenz, Girish Dhall, Tom B. Davidson, Anat Erdreich-Epstein, Debra Hawes, Kyle Hurth, Ashley Margol, Anna Mathew, Nathan R...> ;Neuro-Oncology Advances. 2021 Jan 1
• 4 citations
  Molecular Pathology Economics 101: An Overview of Molecular Diagnostics Coding, Coverage, and Reimbursement: A Report of the Association for Molecular Pathology.
  Anthony N. Sireci, Jay Patel, Loren Joseph, Matthew C. Hiemenz, Oana Rosca, Samuel Caughron, Sarah A. Thibault-Sennett, Tara L. Burke, Dara L. Aisner> ;The Journal of Molecular Diagnostics. 2020 Aug 1
• 3 citations
  Therapeutic Gene Editing with CRISPR: A Laboratory Medicine Perspective.
  Elan Hahn, Matthew C. Hiemenz> ;Clinics in Laboratory Medicine. 2020 Jun 1
• 50 citations
  Expanding the spectrum of dicer1-associated sarcomas.
  Mikako Warren, Matthew C. Hiemenz, Ryan J. Schmidt, Jared Shows, Jennifer A. Cotter, Stephanie Toll, David M. Parham, Jaclyn A. Biegel, Leo Mascarenhas, Rachana Shah> ;Modern Pathology. 2020 Jan 1
• 4 citations
  NTRK‐rearranged mesenchymal tumour in a 3‐year‐old female: a diagnostic quandary
  Mikako Warren, Dean M. Anselmo, Moe Takeda, Nick Shillingford, Matthew C. Hiemenz, Rachana Shah> ;Histopathology. 2019 Aug 2
• 4 citations
  Novel TRIM24-MET Fusion in a Neonatal Brain Tumor
  Matthew C. Hiemenz, Mary M. Skrypek, Jennifer A. Cotter, Jaclyn A. Biegel> ;JCO Precision Oncology. 2019 Apr 25
• 49 citations
  OncoKids: A Comprehensive Next-Generation Sequencing Panel for Pediatric Malignancies
  Matthew C. Hiemenz, Dejerianne Ostrow, Tracy M. Busse, Jonathan D. Buckley, Dennis T. Maglinte, Moiz Bootwalla, James Done, Jianling Ji, Gordana Raca, Alex Ryutov, Xin...> ;The Journal of Molecular Diagnostics. 2018 Nov 1
• 55 citations
  Myeloid lineage switch following chimeric antigen receptor T‐cell therapy in a patient with TCF3‐ZNF384 fusion‐positive B‐lymphoblastic leukemia
  Matthew J. Oberley, Paul S. Gaynon, Deepa Bhojwani, Michael A. Pulsipher, Rebecca Gardner, Matthew C. Hiemenz, Jianling Ji, Jennifer Han, Maurice R.G. O'Gorman, Alan S...> ;Pediatric Blood & Cancer. 2018 Sep 1
• 9 citations
  Three synchronous malignancies in a patient with DICER1 syndrome.
  Diana J. Moke, Stefanie M. Thomas, Matthew C. Hiemenz, Ali Nael, Kasper S. Wang, Nick Shillingford, Jaclyn A. Biegel, Leo Mascarenhas> ;European Journal of Cancer. 2018 Jan 31
• 5 citations
  A neoplasm with FIP1L1-PDGFRA fusion presenting as pediatric T-cell lymphoblastic leukemia/lymphoma without eosinophilia.
  Matthew J. Oberley, Christopher C Denton, Jianling Ji, Matthew C. Hiemenz, Deepa Bhojwani, Dejerianne Ostrow, Samuel Wu, Paul S. Gaynon, Gordana Raca> ;Cancer Genetics. 2017 Oct 1
• 4 citations
  Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors.
  Alan J. Fox, Matthew C. Hiemenz, David B. Lieberman, Shrey Sukhadia, Barnett Li, Joseph Grubb, Patrick Candrea, Karthik Ganapathy, Jianhua Zhao, David Roth, Evan W. Al...> ;Journal of Visualized Experiments. 2016 Sep 20
• 10 citations
  Building a Robust Tumor Profiling Program: Synergy between Next-Generation Sequencing and Targeted Single-Gene Testing
  Matthew C. Hiemenz, Stephan Kadauke, David B. Lieberman, David Roth, Jianhua Zhao, Christopher D. Watt, Robert Daber, Jennifer J.D. Morrissette> ;Plos One. 2016 Apr 4
• 4 citations
  Crossing boundaries: a comprehensive survey of medical licensing laws and guidelines regulating the interstate practice of pathology.
  Matthew C. Hiemenz, Stanley T. Leung, Jason Y. Park> ;The American Journal of Surgical Pathology. 2014 Mar 1
• 22 citations
  High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II-III astrocytomas and oligoastrocytomas.
  Kimmo J. Hatanpaa, Tianshen Hu, Vamsidhara Vemireddy, Chan Foong, Jack M Raisanen, Dwight H Oliver, Matthew C. Hiemenz, Dennis K. Burns, Charles L. White, L. Anthony W...> ;Journal of Neuro-Oncology. 2014 Feb 12
• 1 citations
  Coexistence of t(12;21)(p13;q22)/ETV6-RUNX1 and 11q23/MLL Rearrangement in B Acute Lymphoblastic Leukemia: A Case Report and Review of the Literature.
  Matthew C. Hiemenz, Weina Chen, Naomi J. Winick, Rolando Garcia, Carlos A Tirado> ;Journal of the Association of Genetic Technologists. 2011 Jan 1
• 16 citations
  Novel JAK2 rearrangement resulting from a t(9;22)(p24;q11.2) in B-acute lymphoblastic leukemia
  Carlos A Tirado, Weina Chen, Lily Jun Shen Huang, Carrie E. Laborde, Matthew C. Hiemenz, Federico Valdez, Kevin Ho, Naomi J. Winick, Zhenjun Lou, Prasad Koduru> ;Leukemia Research. 2010 Dec 1
• Join now to see all